NoneTravis Kelce Sends 3-Word Message After Chiefs-Panthers Game - Athlon SportsAmerica’s News Influencers
NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global active pharmaceutical ingredients market size is estimated to grow by USD 86.47 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.73% during the forecast period. Evolving api manufacturing scenario in developing scenario is driving market growth, with a trend towards paradigm shift in api manufacturing. However, high investment cost and concern of huge loss poses a challenge. Key market players include AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF Market Driver Pharmaceutical companies have historically relied on in-house capabilities for API discovery, development, and manufacturing. However, the last few decades have seen a shift towards outsourcing these processes to Contract Manufacturing Organizations (CMOs) or other drug manufacturing entities. Initially, this was driven by necessity, but it has since evolved into an effective collaboration model. The value chain for APIs has expanded from early-stage intermediates to advanced intermediates and final dosage forms. The decision to outsource an API depends on industry trends, cost of new technologies, and internal capacity. Small organizations particularly benefit from outsourcing due to cost savings and time efficiencies. Outsourcing enables companies to meet aggressive development timelines and capitalize on supply chain efficiencies, contributing to the growth of the active pharmaceutical ingredients market. The outsourcing trend is expected to continue as companies focus on reducing time to market and increasing innovation. The Active Pharmaceutical Ingredients (API) market is experiencing significant trends in various sectors. In formulation development, excipients play a crucial role, with companies like Chasse-sur-Rhône and NovasepPharmaZell Group leading the way. Teva Pharmaceutical and MEDinCell are making strides in Schizophrenia and chronic diseases research. Counterfeit drugs pose a threat, driving the need for increased investment in research and development. Infectious diseases, genetic disorders, cardiovascular diseases, and chronic disorders continue to be major focus areas. Biologics and biosimilars are on the rise, with CuraTeQ Biologics, Mendus AB, GenScript ProBio, and GeneCraft leading the charge. Key APIs include Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, and Tamoxifen. Prescription drugs in Cardiology, CNS Neurology, and Oncology are over-clinical, with large molecule and small molecule APIs in high demand. Captive and merchant API manufacturers like Eurofins play essential roles in supplying these essential ingredients. Key APIs include Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, and Tamoxifen. The market for prescription drugs in Cardiology, CNS Neurology, and Oncology remains over-clinical, with large molecule and small molecule APIs in high demand. Captive and merchant API manufacturers like Eurofins play essential roles in supplying these essential ingredients. Some of the major APIs in focus are Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, and Tamoxifen. The market for prescription drugs in Cardiology, CNS Neurology, and Oncology remains over-clinical, with large molecule and small molecule APIs in high demand. Captive and merchant API manufacturers like Eurofins play essential roles in supplying these essential ingredients. In the API market, trends include a focus on excipients, biologics and biosimilars, and a continued emphasis on research and development to combat counterfeit drugs and address the needs of chronic diseases such as Schizophrenia, infectious diseases, genetic disorders, cardiovascular diseases, and chronic disorders. Key APIs include Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, and Tamoxifen, with applications in prescription drugs for Cardiology, CNS Neurology, and Oncology. Captive and merchant API manufacturers like Eurofins play essential roles in supplying these ingredients. Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution! Market Challenges The Active Pharmaceutical Ingredients (API) market faces significant challenges in various therapeutic areas. In oncology, biosimilars are disrupting the market, leading to price pressure and increased competition. Cancer research continues to drive demand for APIs in oncology drugs. Diabetes is another major therapeutic area, with APIs for insulins and oral medications in high demand. CuraTeQ Biologics, Mendus AB, GenScript ProBio, GeneCraft, NovasepPharmaZell Group, Eurofins, and others are key players in the market. Small molecule APIs like Acetaminophen, Ibuprofen, Losartan Potassium, and Naproxen continue to dominate, but large molecule APIs for Prescription Drugs in Cardiology, CNS Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Nephrology, Ophthalmology, and other therapeutic applications are gaining popularity. Captive API Manufacturers and Merchant API Manufacturers must navigate these challenges to meet the demand for APIs in a competitive and evolving market. Some notable APIs include Artemisinin for Malaria treatment, Saxagliptin for Diabetes, Sodium Chloride for various applications, Enoxaparin Sodium for Anticoagulation, Rufinamide for Epilepsy, and Tamoxifen for Breast Cancer. Over clinical trials and regulatory approvals are crucial for bringing new APIs to market. Discover how AI is revolutionizing market trends- Get your access now! Segment Overview This active pharmaceutical ingredients market report extensively covers market segmentation by 1.1 Captive APIs 1.2 Contract APIs 2.1 Innovative APIs 2.2 Generic APIs 3.1 Asia 3.2 North America 3.3 Europe 3.4 Rest of World (ROW) 1.1 Captive APIs- The captive API manufacturing segment holds the largest share in the global Active Pharmaceutical Ingredients (API) market due to the increasing development of biopharmaceutical products and the emphasis on quality control. The healthcare industry's focus on affordable healthcare services has driven the demand for low-cost APIs, leading some innovators to outsource to Contract Manufacturing Organizations (CMOs). However, the expiry of patents on blockbuster drugs has slowed down the growth of the API market for these drugs. In contrast, the API market for generic drugs is booming due to the increasing production capacity. The development of biopharmaceutical products requires significant investment and the risk of financial loss due to small variations in APIs, making in-house capabilities essential for innovators. Regulatory authorities' emphasis on quality control further increases the dependency on in-house API manufacturing. Major pharmaceutical companies, such as Pfizer, Novartis, Sanofi, and GlaxoSmithKline Plc, are investing in in-house API capabilities to drive the growth of the captive API segment and expand the global API market. Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics Research Analysis The Active Pharmaceutical Ingredients (API) market encompasses the production and supply of Excipients, the non-active components used in pharmaceutical formulations, and the Active Pharmaceutical Ingredients themselves. These substances play a crucial role in the therapeutic effect of medicines. The market caters to various therapeutic areas such as Chasse-sur-Rhône for Schizophrenia, Chronic diseases, Infectious diseases, Genetic disorders, Cardiovascular diseases, and Chronic disorders. The market is driven by research and investment in Biologics, Biosimilars, Cancer, Oncology drug research, Diabetes, Small Molecule, and Large Molecule APIs. The market also addresses the challenge of Counterfeit drugs, ensuring the production of high-quality APIs. Notable sub-segments include Captive API Manufacturer and Merchant API Manufacturer. Examples of APIs include Acetaminophen, Artemisinin, and many others used in treating diverse medical conditions. Market Research Overview The Active Pharmaceutical Ingredients (API) market encompasses the production and supply of Excipients, the non-active components used in pharmaceutical formulations, and APIs, the essential substances that provide therapeutic effects. The market caters to various therapeutic areas such as Schizophphrenia, Chronic diseases, Infectious diseases, Genetic disorders, Cardiovascular diseases, and Chronic disorders. APIs are integral to Biologics, Biosimilars, and Oncology drug research, including for treatments in Cardiology, CNS Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Nephrology, Ophthalmology, and other therapeutic applications. Key challenges in the market include counterfeit drugs, lack of demand, and regulatory compliance. Notable APIs include Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, and Prescription Drugs like Over-the-counter (OTC) and Clinical trial drugs. Major players in the market include Captive API Manufacturers and Merchant API Manufacturers. Some notable companies are Chasse-sur-Rhône, Teva Pharmaceutical, MEDinCell, Schizophrenia, CuraTeQ Biologics, Mendus AB, GenScript ProBio, GeneCraft, NovasepPharmaZell Group, and Eurofins. APIs are used in the production of Small Molecule and Large Molecule drugs, with key examples being Acetaminophen (Small Molecule) and Biologics (Large Molecule). Other significant APIs include Artemisinin (Antimalarial), Saxagliptin (Diabetes), Sodium Chloride (Pharmaceutical Excipient), Ibuprofen (Analgesic), Losartan Potassium (Antihypertensive), Enoxaparin Sodium (Anticoagulant), Rufinamide (Anticonvulsant), Naproxen (Analgesic), and Tamoxifen (Antiestrogen). The market is driven by research and investment in various therapeutic areas, including Cancer, Oncology drug research, and Diabetes. Key diseases targeted include Schizophrenia, Chronic diseases, Infectious diseases, Genetic disorders, Cardiovascular diseases, and Chronic disorders. Some notable APIs in the market include Acetaminophen (Analgesic and Antipyretic), Artemisinin (Antimalarial), Saxagliptin (Diabetes), Sodium Chloride (Pharmaceutical Excipient), Ibuprofen (Analgesic and Anti-inflammatory), Losartan Potassium (Antihypertensive), Enoxaparin Sodium (Anticoagulant), Rufinamide (Anticonvulsant), Naproxen (Analgesic and Anti-inflammatory), and Tamoxifen (Antiestrogen). The market is segmented into Small Molecule and Large Molecule APIs. Small Molecule APIs are typically synthesized using chemical reactions, while Large Molecule APIs are produced using biotechnological processes. The market is also influenced by various factors such as regulatory compliance, counterfeit drugs, and the shift towards personalized medicine and biosimilars. Regulatory compliance is crucial in ensuring the safety and efficacy of APIs, while the rise of counterfeit drugs poses a significant challenge to market growth. The shift towards personalized medicine and biosimilars is expected to create new opportunities for API manufacturers. Some notable companies in the market include Chasse-sur-Rhône, Teva Pharmaceutical, MEDinCell, Schizophrenia, CuraTeQ Biologics, Mendus AB, GenScript ProBio, GeneCraft, NovasepPharmaZell Group, and Eurofins. Chasse-sur-Rhône is a leading player in the API market, with a focus on the production of Small Molecule APIs. Teva Pharmaceutical is another major player, with a strong presence in both Small Molecule and Large Molecule APIs. MEDinCell specializes in the production of Large Molecule APIs, while Schizophrenia focuses on the development and production of APIs for the treatment of Schizophrenia and other CNS disorders. CuraTeQ Biologics, Mendus AB, GenScript ProBio, GeneCraft, and NovasepPharmaZell Group are other notable players in the market, with a focus on the production of Large Molecule APIs. Eurofins is a leading provider of contract research services, including API development and manufacturing. The market for APIs is expected to grow significantly in the coming years, driven by research and investment in various therapeutic areas, including Cancer, Oncology drug research, and Diabetes. The increasing prevalence of chronic diseases, such as cardiovascular diseases and diabetes, is also expected to fuel market growth. Some notable APIs in the market include Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, and Tamoxifen. Acetaminophen is a widely used analgesic and antipyretic, while Artemisinin is an essential component in the treatment of malaria. Saxagliptin is a popular diabetes drug, while Sodium Chloride is a common pharmaceutical excipient. Ibuprofen is an analgesic and anti-inflammatory drug, while Losartan Potassium is an antihypertensive. Enoxaparin Sodium is an anticoagulant, Rufinamide is an anticonvulsant, Naproxen is an analgesic and anti-inflammatory drug, and Tamoxifen is an antiestrogen. The market for APIs is segmented into Small Molecule and Large Molecule APIs. Small Molecule APIs are typically synthesized using chemical reactions, while Large Molecule APIs are produced using biotechnological processes. Small Molecule APIs are typically less complex and can be produced in larger quantities, making them more cost-effective. However, they may have limited therapeutic effects and may require the use of multiple APIs to achieve the desired therapeutic outcome. Large Molecule APIs, on the other hand, are more complex and may require more specialized production processes. They are typically more expensive to produce but may offer more targeted therapeutic effects. The market for APIs is influenced by various factors, including regulatory compliance, counterfeit drugs, and the shift towards personalized medicine and biosimilars. Regulatory compliance is crucial in ensuring the safety and efficacy of APIs, while the rise of counterfeit drugs poses a significant challenge to market growth. The shift towards personalized medicine and biosimilars is expected to create new opportunities for API manufacturers. The market for APIs is expected to grow significantly in the coming years, driven by research and investment in various therapeutic areas, including Cancer, Oncology drug research, and Diabetes. The increasing prevalence of chronic diseases, such as cardiovascular diseases and diabetes, is also expected to fuel market growth. Some of the key challenges facing the API market include regulatory compliance, counterfeit drugs, and the shift towards personalized medicine and biosimilars. Regulatory compliance is crucial in ensuring the safety and efficacy of APIs, while the rise of counterfeit drugs poses a significant challenge to market growth. The shift towards personalized medicine and biosimilars is expected to create new opportunities for API manufacturers. Regulatory compliance is a major challenge for API manufacturers, as they must adhere to strict regulations to ensure the safety and efficacy of their products. This includes compliance with Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), as well as regulatory requirements for the registration and approval of APIs. Counterfeit drugs are another significant challenge for the API market, as they can pose a risk to patient safety and undermine the credibility of legitimate API manufacturers. Counterfeit drugs may contain substandard or contaminated APIs, which can lead to adverse reactions or ineffective treatments. The shift towards personalized medicine and biosimilars is expected to create new opportunities for API manufacturers, as these treatments require the production of more complex APIs. Personalized medicine and biosimilars offer more targeted therapeutic effects and can reduce the cost of treatments, making them more accessible to patients. Some of the key trends in the API market include the increasing use of biotechnological processes for the production of Large Molecule APIs, the growing demand for biosimilars and personalized medicines, and the increasing focus on regulatory compliance and quality control. The increasing use of biotechnological processes for the production of Large Molecule APIs is a significant trend in the market, as these processes offer more targeted therapeutic effects and can reduce the production costs of complex APIs. Biotechnological processes involve the use of living organisms or cells to produce APIs, which can result in more complex and effective therapeutic agents. The growing demand for biosimilars and personalized medicines is another key trend in the API market, as these treatments offer more targeted therapeutic effects and can reduce the cost of treatments. Biosimilars are generic versions of biologic drugs, while personalized medicines are tailored to the individual needs of patients based on their genetic makeup or other factors. The increasing focus on regulatory compliance and quality control is also a significant trend in the API market, as regulatory agencies continue to tighten their requirements for the safety and efficacy of APIs. This includes the implementation of stricter GMP and GLP regulations, as well as the use of advanced technologies for quality control and testing. In conclusion, the API market is a dynamic and growing industry, driven by research and investment in various therapeutic areas and the increasing prevalence of chronic diseases. The market is segmented into Small Molecule and Large Molecule APIs, with each offering unique advantages and challenges. The market is influenced by various factors, including regulatory compliance, counterfeit drugs, and the shift towards personalized medicine and biosimilars. The increasing use of biotechnological processes for the production of Large Molecule APIs, the growing demand for biosimilars and personalized medicines, and the increasing focus on regulatory compliance and quality control are some of the key trends in the market. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Manufacturing Type Captive APIs Contract APIs Type Innovative APIs Generic APIs Geography Asia North America Europe Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE TechnavioDelaware judge reaffirms ruling that invalidated massive Tesla pay package for Elon MuskBizarre move that could backfire for title contender; GOAT’s big challenge: NBL Report Card2025 could be a busy year for young people in Burk’s Falls. Several Burk’s Falls residents, including parents, have created a youth centre proposal designed for 12- to 18-year-olds. Barry Burton of nearby Ryerson Township proposed the concept at the Burk’s Falls Dec. 17 meeting and received positive responses. According to the 2021 census, 20 per cent of Burk’s Falls population was made up of people under 20, and Burton says that the youth population has increased since that time. Burton adds that according to a Government of Canada State of Youth Report from 2021, many young people face issues like cyber bullying, social exclusion and mental health challenges. He adds the “numbers are staggering” because we have 53 per cent of young people aged 15 to 18 who struggle with depression and mental health. “And suicide is the second leading cause of death among young people in Canada,” Burton told town council. The proposed Burk’s Falls Youth Centre would be drug-free and bully-free and provide a safe environment. Burton says with the help from guest speakers and instructors, the centre would provide guidance and mentorship and leadership skills and explain the dangers of substance abuse. At the same time, the young people would be exposed to various programs, including the arts, music and technology, and learn the value of cooking one’s own meals. Burton is no stranger to helping to start a youth centre. In 2014, he was the deputy mayor of Clearview Township near Barrie, which includes the rural community of Stayner. Burton told Almaguin News Stayner “is very similar to Burk’s Falls” and there wasn’t much for young people to do. During an all-candidates debate in 2014, the people running for town council were asked by young people what their plan was for the youth of the township. Once elected, Burton and council set out to create the Stayner Youth Centre and raised $100,000 in three months, including $20,000 from the United Way, in addition to corporate grants and money from all three government levels. “We started with 12 young people coming in on a regular basis five days a week and now there are more than 200 youth who are part of the centre,” Burton said. Burton left Clearview Township two years ago for Ryerson Township in the Almaguin Highlands. He was at a local historical society meeting in 2023 when people began talking about the lack of things for young people to do. Burton told the group he could help thanks to his recent experience in Stayner. During 2023 and into 2024, parents and adults interested in ensuring young people have things to do began meeting, and the ad hoc group was formed. One of those parents who is part of the group is Mary Thomson, who has 10- and 12-year-old boys and also lives in Ryerson. “They’re excited,” Thomson said about her boys’ reaction upon learning there might soon be a youth centre in Burk’s Falls. “There are no hubs for them. They can just go to their friends’ homes.” Thomson understands what her sons experience because she grew up in Burk’s Falls and also faced the age-old question of what to do in a small, rural community. “It could be boring and you would get into trouble,” Thomson said, adding she wasn’t one of the trouble makers. Corinne Penstone is a Burk’s Falls mother with twin 12-year-old boys and a seven-year-old daughter. Penstone says one thing the group wants to do is go into the schools and ask the students themselves what they need. “We want to involve them in this,” Penstone said. “My boys are pumped that we care about what they want.” Penstone adds that assuming the youth centre becomes reality, the committee would like to see some of the students become volunteers and act as the bridge between the committee and the young people at the centre. Burton says the local group has created a $93,030 budget, with $18,000 of that paying for rent and a further $43,680 covering the salary of a youth engagement co-ordinator. Volunteers would help the co-ordinator. The group has looked at three sites in downtown Burk’s Falls, but has made no commitments. Burton doesn’t find the task of raising close to $100,000 daunting. “I have experience getting this kind of thing off the ground,” he said. “It’s a lot of work, but we have a great committee that is ready to go.” Burton says $3,200 is already in place “and we haven’t even started yet.” Burton says there are federal, provincial and corporate grants available, and one simply has to know how to go about accessing those funds. What he and the committee are requesting of the council is that the youth centre group become a committee of council. “This opens the doors to municipal resources for us,” he said. Burton said the committee could apply to become a non-profit organization, but the paperwork to launch and maintain that status eats up money that could be applied to the youth centre. As a committee of council, Burton explained, the mechanism already exists for the municipality to provide donation receipts to people and businesses who contribute to the centre. During the school year, the centre would operate weekdays from 3 p.m. to 8 p.m., and Burton says a different format would be needed if the facility is also open on weekends and during the summers. Burton says the group has been asked to draw up terms of reference for council’s consideration and formally elect officers as council members discuss his request for the group to become a committee of council. Burton says he’s optimistic that council will agree to the request, and that word of that agreement could come early in the new year. Rocco Frangione is a Local Journalism Initiative reporter with Almaguin News. The Local Journalism Initiative is funded by the Government of Canada.
By TravelPulse (TNS) While 2024 was a year that brought about significant, continued post-pandemic recovery for the travel industry, it was also a period of time marked by instability in some locations around the world. From attacks on the rail lines during the Paris Olympics to the ongoing conflicts in the Middle East, not to mention the war in Ukraine, the global travel realm in 2024 was fraught with challenges. It is against this backdrop that the international security and medical services provider Global Guardian recently released its 2025 Global Risk Map. Published annually, the map is meant to help travelers better understand the current global risk landscape. In order to develop its guidance, experts at Global Guardian assess a long list of country-specific security risk factors and indicators, including crime, health, natural disasters, infrastructure, political stability, civil unrest and terrorism. For 2025, Global Guardian’s assessment results underscore the reality that disruption globally and domestically continues to increase, and now more than ever travelers need to be prepared when exploring the world. As part of the latest assessment, Global Guardian highlighted a handful of specific global regions that are at particular risk of destabilization over the next year and beyond. Here’s a closer look at those regions, along with insights from Global Guardian CEO Dale Buckner, who recently spoke with TravelPulse at length about the risks travelers may face in 2025. Here are the regions at risk of destabilization in 2025: Israel’s existential battle against Iran is set to continue into 2025, says the Global Guardian report. “In July 2024, Israel assassinated Hamas’ political leader, Ismail Haniyeh, in an Iranian Revolutionary Guard Corps (IRGC) safehouse in Tehran, and Iran has pledged revenge,” the report explains. “This comes as Iran and its web of regional proxies took their war on Israel out of the shadows and into the open following October 7, 2023, with seven live fronts.” Global Guardian also predicts that Israel’s regional war will shift from Gaza to the West Bank and Lebanon in the year ahead, heightening tensions with Hezbollah, while Houthi attacks on commercial shipping in the Red Sea and Indian Ocean will persist. The report adds that as “we enter 2025, Israel may assess that its strategic window to prevent a nuclear Iran is rapidly closing and choose to act.” The ongoing civil war in Sudan between the Sudanese Armed Forces (SAF) and the Rapid Support Forces (RSF), is also of concern, according to Global Guardian’s risk analysis. The conflict “has created a dire humanitarian situation with ethnically motivated violence on the rise,” says the report. Some of the areas of concern in the Latin American region include Venezuela and Mexico, according to Global Guardian. The risk in Venezuela is tied to the country’s long-standing territorial dispute with neighboring Guyana, says the report. “Since 2019, the U.S. Department of State withdrew all diplomatic personnel from U.S. Embassy Caracas and suspended all operations,” explains Buckner. “Violent crimes, such as homicide, armed robbery, kidnapping, and carjacking, are common in Venezuela. Shortages of gasoline, electricity, water, medicine, and medical supplies continue throughout much of Venezuela. Simply put, Venezuela is one of the most dangerous countries in the world for Western travelers and should be avoided.” In Mexico, meanwhile, the problems include drug cartel-related violence and theft, among other issues, says the report. Mexico recently inaugurated its first female president, Claudia Sheinbaum, and like her predecessors she will face challenges “reining in cartel violence, corruption, extortion, theft and kidnapping,” says the report. “As such, security continues to be a top concern in Mexico’ ” says the report, which categorizes Mexico as “high risk” when it comes to travel for 2025. Countries classified as high risk experience regular conflict, criminal activity or civil unrest — and have not effectively managed those risks. The Global Guardian report also suggests there may be heightened risks in Mexico now that Donald Trump has been reelected U.S. president. “Bilateral relations between the U.S. and Mexico could dramatically deteriorate. Trump has promised a mass deportation operation, which could sour relations between the U.S. and Mexico, increasing risks to businesses operating in Mexico,” the report adds. Asked to comment on Mexico’s high-risk designation, Buckner stressed that the situation in the country is extremely nuanced, adding that it’s a vast oversimplification to call the entire country high risk. “There are pockets of Mexico that are wildly safe and wonderful to visit and people shouldn’t hesitate to go,” Buckner told TravelPulse. “And there are also pockets that are unsafe and dangerous.” The good news, added Buckner, is that Mexico’s new president is focusing a great deal of effort and energy on addressing the problems surrounding drug cartels, which are the source of a great deal of the risk. Buckner was quick to add however, that as long as there’s demand for drugs, the drug cartel situation is likely to remain problematic. “The U.S. is driving the drug demand — we consume more drugs then the rest of the world,” explained Buckner. “It’s really overly simplified to paint Mexico as the bad guy, because if there wasn’t demand, we wouldn’t need the supply. But the demand is real and violence comes with that.” Representatives for Global Nexus, a government and public affairs consultancy that advises travel and tourism companies and interests in Southern Mexico, told TravelPulse that while drug-related violence has been known to occur, it involves members of the drug cartel targeting each other, they’re not targeting tourists. “There is an ongoing battle between small drug vendors who use the beach to sell product to tourists hanging out on the beach,” explained Ruben Olmos, Global Nexus president and CEO, in reference to the Quintana Roo region, which is popular with tourists. “There have been cases where gunfire has been exchanged between these groups. They are targeting themselves. They are fighting over ‘This is my beach’ and they initiate a shootout.” However, added Olmos, that the U.S. State Department’s risk categorization for Quintana Roo (which is separate from the Global Guardian risk assessment) has not changed. Located on the State Department’s Mexico page, the risk assessment for Quintana Roo remains in the “Exercise Increased Caution” category, which is below the top risk categories of “Do Not Travel” and “Reconsider Travel.” The Exercise Increased Caution designation means “Be aware of heightened risks to safety and security,” explains the State Department’s website. Olmos also pointed out that Mexico is the only country that has a map on the U.S. State Department website that covers every single state in the country, providing details for travelers about which states are safest. In June 2024, thousands of young people took to the streets in Kenya to protest a controversial tax bill. The protesters were met with heavy-handed policing, including the use of live fire and mass arrests, says the Global Guardian risk report. Despite the local security response, protests continued. The success and tenacity of the Kenyan movement has triggered similar protests or dissent in other countries including Uganda, Tanzania, South Africa, and Nigeria, says Global Guardian. That is just a portion of the risk Global Guardian sees for Sub-Saharan Africa over the course of 2025. “With multiple conflicts escalating across the continent, aging leaders leaving behind unclear successions, and entrenched regimes with dissipating legitimacy, Sub-Saharan Africa now looks much like the North African and Arab world in the early 2010s,” says the report. “While the dynamic unfolding in Africa might not yet merit the label of “African Spring,” a significant change to the continent’s political status quo is coming.” Several countries received an extreme or high-risk designation on the new Global Guardian risk map for 2025, including more than a few that are popular with leisure travelers or tourists. Extreme risk countries are those that Global Guardian says are “actively engaged in conflict, while also experiencing severe criminal activity and civil unrest.These countries are insecure; state institutions are too weak to manage militant groups or large-scale disasters.” They include Afghanistan, Burkina Faso, Central African Republic, Lebanon, Mali, Niger, Somalia, Ukraine, West Bank, Gaza and Yemen. The current list of high-risk countries, which are countries that experience regular conflict, criminal activity or civil unrest and have not effectively managed those risks, includes Bangladesh, Cameroon, Democratic Republic of Congo, Ecuador, Ethiopia, Guatemala, Honduras, Iraq, Israel, Jamaica, Kenya, Libya, Mexico, Mozambique, Myanmar, Nigeria, Pakistan, Papua New Guinea, South Sudan, Uganda, Venezuela Officials from the Jamaica Tourist Board provided a statement to TravelPulse in response to Global Guardian’s designation of the country. “Last month, Global Guardian, a private security provider, released its 2025 Global Risk Map, which included Jamaica, amongst other destinations,” said the Tourist Board. “It is important to note that the crime rate against visitors is notably low at 0.01% and the majority of Jamaica’s tourism product remains unaffected.” The country’s tourism officials added that Jamaica has welcomed 3 million visitors this year and boasts a high repeat visitor rate of 42%. “The island is consistently ranked among the top destinations for international travel and visitors continue to come with confidence to enjoy all that Jamaica has to offer,” the statement adds. When it comes to Jamaica, Buckner offered similar comments to those of Mexico, noting that the situation is impacted by drug-related violence and the experience on the ground is nuanced and cannot be painted with a broad brush. “In the same vein as Mexico — Jamaica can be a wonderful place to visit,” says Buckner. “There are pockets of beauty and low crime and as long as you are careful, it’s a very low threat.” Buckner, a retired Army colonel, maintains that the world is indeed a more risky place heading into 2025. The challenges in the Middle East and Ukraine are at the forefront of the instability, but are hardly the only cause for concern. “Israel has now gone to Gaza and cleaned out Hamas, they’re now moving north into Lebanon, and we are convinced Israel will strike Iran,” Buckner said during an interview that took place prior to Israel’s strike on Iran. “If that occurs you are going to see violence across the Middle East.” “But there are over 100 conflicts across the globe,” continues Buckner. When you combine that reality with other challenges the world is currently grappling with, including the destabilizing influences of climate change, there are plenty of risks for travelers to bear in mind when planning a journey for the coming year. He wraps up by offering a few tips for travelers, a check-list of sorts, to work through when planning or considering travel to a specific country in 2025: — If you don’t know who to call or how you are going to negotiate if someone is kidnapped, you shouldn’t go there. — Consumers need to read the fine print on travel insurance because it does not cover war zones, terrorism or natural disasters, says Buckner. And travelers are often surprised and find out too late that these types of events are not covered. — If you get stuck or stranded, if you don’t know who you are going to call to get you out of that situation, know what organizations locally or internationally are available to help you. ©2024 Northstar Travel Media, LLC. Visit at travelpulse.com. Distributed by Tribune Content Agency, LLC.
Shohei Ohtani likely to win his third MVP award and Aaron Judge his second NEW YORK (AP) — Shohei Ohtani is expected to win his third Most Valuable Player Award and first in the National League, and Aaron Judge is likely to earn his second AL honor when the Baseball Writers’ Association announces its balloting. Ohtani was unanimously voted the AL MVP in 2021 and 2023 as a two-way star for the Los Angeles Angels. He signed a record $700 million, 10-year contract with the Los Angeles Dodgers last December. Ohtani hit .310, stole 59 bases and led the NL with 54 homers and 130 RBIs, becoming the first player with 50 or more homers and 50 or more stolen bases in a season. He helped the Dodgers to the World Series title. Alex Ovechkin is expected to miss 4 to 6 weeks with a broken left leg Alex Ovechkin has a broken left fibula and is expected to be out four to six weeks. The Washington Capitals confirmed Ovechkin’s injury and prognosis Thursday after he was evaluated by doctors upon the teams’ return from a three-game road trip. This prolonged absence puts a pause on Ovechkin’s pursuit of Wayne Gretzky’s NHL career goals record. He scored 15 goals in his first 18 games this season to move just 27 away of passing Gretzky. Ovechkin was on pace to break the record in February before his shin-on-shin collision with Utah’s Jack McBain on Monday night. NFL issues security alert to teams and the players' union following recent burglaries The NFL has issued a security alert to teams and the players’ union following recent burglaries involving the homes of Chiefs stars Patrick Mahomes and Travis Kelce. In a memo obtained by The Associated Press, the league says homes of professional athletes across multiple sports have become “increasingly targeted for burglaries by organized and skilled groups.” Law enforcement officials noted these groups target the homes on days the athletes have games. Players were told to take precautions and implement home security measures to reduce the risk of being targeted. Some of the burglary groups have conducted extensive surveillance on targets. QB Daniel Jones disagrees with the Giants' decision to bench him and says he wants to play EAST RUTHERFORD, N.J. (AP) — With tears occasionally welling in his eyes, Daniel Jones disagreed on Thursday with the New York Giants' decision to bench him earlier this week and perhaps end his five-plus tenure as the team’s quarterback. The 27-year-old Jones said he gave the team everything he had after being taken sixth overall in the 2019 draft and he believes he still has a future in the NFL. He held himself accountable for the Giants making the playoffs once in his tenure as the starter. Penn State wins trademark case over retailer's use of vintage logos, images PHILADELPHIA (AP) — Penn State has won a closely watched trademark fight over an online retailer’s use of its vintage logos and images. A Pennsylvania jury awarded Penn State $28,000 in damages earlier this week over products made and sold by the firms Vintage Brand and Sportswear Inc. Penn State accused the firms of selling counterfeit clothing and accessories. The defendants said their website makes clear they are not affiliated with Penn State. At least a dozen other schools have sued the defendants on similar grounds, but the Pennsylvania case was the first to go to trial. Defense lawyers declined to comment on the verdict and whether they planned an appeal. Guardiola signs a 2-year contract extension at Man City and eyes 'more trophies' MANCHESTER, England (AP) — Pep Guardiola’s record-breaking time with Manchester City is far from over. The City manager has signed a two-year contract extension ending speculation about his future by agreeing to a deal that would prolong his tenure to 11 seasons. Guardiola’s contract was due to expire at the end of this season. The four-time defending Premier League champions announced the deal Thursday. The Catalan coach has overseen a period of unprecedented dominance since joining City in 2016. He has gone on to win six Premier League titles in seven years and also lifted the Champions League among 15 major trophies at the club. Jannik Sinner leads Italy back to the Davis Cup semifinals and a rematch against Australia MALAGA, Spain (AP) — No. 1-ranked Jannik Sinner has led defending champion Italy to a comeback victory over Argentina for a return to the Davis Cup semifinals. A rematch of last year's championship matchup against Australia now awaits in the final four on Saturday in Malaga, Spain. Italy fell behind 1-0 in the quarterfinals when Argentina's Francisco Cerúndolo defeated Lorenzo Musetti 6-4, 6-1. But two-time Grand Slam champion Sinner overwhelmed Sebastián Báez 6-2, 6-1. Then Sinner teamed with Matteo Berrettini in the deciding doubles match to win 6-4, 7-5 against Andres Molteni and Maximo Gonzalez. Australia eliminated the U.S. to reach the Davis Cup semifinals for the third consecutive year. Drama surrounds final 3 races of F1 season as drivers voice displeasure with recent FIA decisions LAS VEGAS (AP) — There’s three races remaining in the Formula 1 season and Max Verstappen is inching so close to a fourth consecutive world championship he could wrap it up Saturday night at the Las Vegas Grand Prix. But all is not smooth sailing headed into this final month of racing. There’s a new race director following the shock sacking of Niels Wittich that blindsided the Grand Prix Driver’s Association so badly they created an Instagram account to rebuke the lack of FIA transparency. It’s the lone post on the account. Greg Maffei, the CEO of Liberty Media said last week he was stepping down from his position and F1 furiously denied over the weekend that Stefano Domenicali, CEO of Formula One Management, was also on the move. Colorado's 2-way star Travis Hunter eyes Big 12 title and more before 'for sure' entering NFL draft DENVER (AP) — Travis Hunter made a pair of proclamations when he announced he’s for sure turning pro after this season, but not until he sees Colorado all the way through the College Football Playoff should the Buffaloes make it there. The first was a given for the junior who plays both receiver and cornerback. The second is a risk-reward play for a projected first-round draft pick who averages around 120 snaps a game. In years past, it took two extra postseason wins to capture a national title. Now, it could take up to four additional contests. That’s more of a chance to shine, but also more chance for an injury. 76ers' star Paul George sidelined the next 2 games with bone bruise in left knee PHILADELPHIA (AP) — Philadelphia 76ers forward Paul George has a bone bruise on his left knee and will miss two games, the team said. The 76ers said George did not suffer any structural damage when he injured the same knee that he hyperextended during the preseason in Wednesday night’s loss at Memphis. George will miss home games Friday against Brooklyn and Sunday against the Los Angeles Clippers. The team says George will be evaluated again on Monday.
A look at how some of Trump's picks to lead health agencies could help carry out Kennedy's overhaulA West Vancouver non-profit is raising funds to help provide opportunities for urban Indigenous people to succeed. On Giving Tuesday, which is Dec. 3, the Urban Spirit Foundation is hosting a fundraiser event where people can enjoy chili and bannock along with sales of baked goods, raffle prizes and a 50/50 draw. “Without fundraisers like this, it would be less money in the pot to be able to do the good work that we’re doing,” said Lynn White, executive director of the Urban Spirit Foundation. White says urban Indigenous people are those who reside in cities, but also those who may not have status or are not connected to their First Nation. The Urban Spirit Foundation is a charitable organization that provide opportunities for Indigenous people living in the city through education and employment training, secondary and post-secondary scholarships and relief of poverty. The fundraiser began shortly after the foundation launched in 2007. Once the team heard about Giving Tuesday, White said they were inspired to use it as a charity fundraising event. The Urban Spirit Foundation works in partnership with the Aboriginal Community Career Employment Services Society (ACCESS), where White is also the CEO. Some of the raffle prizes include Vancouver Canucks tickets and gift cards for Hype Chocolate and Indigenous owned cosmetic brand Cheekbone Beauty. The money collected helps go back into the programs the foundation and ACCESS offer, White said. Since its creation, the foundation has been able to provide scholarships to Indigenous people within the Vancouver and Surrey school districts, British Columbia Institute of Technology (BCIT) and more. I really take pride in being able to give out some scholarships and support our people who are going back to school and trying to struggle their way out of poverty and into a career,” White said. The two organizations also help provide employment opportunities, including the BladeRunners program, that helps give at-risk young people between ages 19 and 30 work experience, certified health and safety training and social skills development. As the hours lead up to the fundraiser, the team is preparing the chili and bannock. “We welcome anybody who would like to come by and support us and have some chili,” White said. Urban Spirit Foundation fundraiser Where: ACCESS head office, 108-100 Park Royal South, West Vancouver When: Dec. 3, 11:30 a.m. to 1 p.m. Admission: $18 Abby Luciano is the Indigenous and civic affairs reporter for the North Shore News. This reporting beat is made possible by the Local Journalism Initiative.
The Block couple shock co-stars with massive personal newsAP Trending SummaryBrief at 5:17 p.m. ESTSpotify Users Discover Adult Content Hidden In Search Results Sparking Outrage Over Moderation Loopholes
Thiruvananthapuram, Dec 30 (PTI) The devastating landslides that wiped away three villages in Wayanad, Congress’ thumping victory in the Lok Sabha polls and AICC general secretary Priyanka Gandhi Vadra’s maiden electoral victory were the significant events that shaped the Kerala’s socio-political scenario in 2024. The revelations of sexual abuse and harassment in the Malayalam film industry, brought to light by the Justice Hema Committee report, also stirred up the political pot due to the delay in disclosing the panel’s findings, which followed allegations of rape against some key actors, including ruling CPI(M) MLA and actor M Mukesh. On 30 July, massive landslides occurred in the Chooralmala and Mundakkai regions of Wayanad, triggered by torrential rains, resulting in over 200 deaths, numerous injuries, and thousands being left homeless. It is considered one of the worst natural disasters in Kerala’s history. Hundreds were left buried under the debris and many had to be pulled out by rescue agencies, which included the Army. Some of the most heart-wrenching scenes, such as the phone conversations of many who cried and pleaded for rescue, emerged. They were either trapped in their homes or could not leave the place where they were left stranded. The calamity again brought into sharp focus the urgent need for better disaster management and preparedness in the southern state, which is being increasingly exposed to extreme weather events as climate change unfolds. But rehabilitation efforts lag behind, leaving the lives of survivors in disarray. The state government has claimed the delay was caused by the central government’s lapse in providing funds. It has moved the court, questioning the union government’s alleged discriminatory approach. In a relief to the state government, another hurdle in implementing rehabilitation efforts was addressed thanks to the Kerala High Court’s intervention, which ruled it can acquire land from two private estates to build a model township for survivors of the landslide, dismissing the companies’ petitions that challenged the government’s decision. Kerala’s political front threw up a few surprises as the ruling LDF saw electoral setbacks. In the Lok Sabha polls, the Congress-led United Democratic Front opposition defeated the CPI(M)-headed Left Democratic Front (LDF). The UDF bagged 18 Lok Sabha seats, most of them with a thumping margin, while the Left could win only one seat. However, the BJP had a lot to cheer as the Lotus finally bloomed in the southern state. The saffron party won its first ever LS seat in Kerala, with the voters of Thrissur giving the thumbs up for actor-turned-politician Suresh Gopi. He scripted history by defeating both the LDF and the UDF in a triangular contest. Analysts say this change in political fortunes reflects the possible shifting of voter preference in the southern state. Kerala also saw Congress General Secretary Priyanka Gandhi Vadra’s maiden electoral foray this year, after she triumphed in the Wayanad Lok Sabha bypoll in November with a thumping margin of over four lakh votes. She surpassed her brother Rahul Gandhi’s victory margin recorded a few months earlier. The by-election was caused by the resignation of Rahul from the hill constituency as he had also won from Raebareli seat in Uttar Pradesh. In the Malayalam cinema world, a new script of shocking revelations unfolded, as the Justice Hema Committee report on sexual abuse made headlines. The executive committee of the actors’ union Association of Malayalam Movie Artists (AMMA), was dissolved as allegations of sexual assault and misconduct grew amid complaints from women against its members. Many actors, including Mukesh, Siddhique, and Edavela Babu had to face probe by a Special investigation team of Kerala police constituted to look into such allegations. Kerala lost one of its literary legends, MT Vasudevan Nair, on December 25. Popularly addressed as MT by his admirers, he was famous for taking Malayalam storytelling to remarkable heights and weaving narratives that captured human life’s complex emotions in addition to the essence of the rural landscape of Kerala. MT was a renowned writer, screenwriter, and filmmaker who significantly influenced the cultural imagination of Kerala and left a lasting impact that extended far beyond to become one of India’s most beloved literary figures. PTI HMP LGK TGB SA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );Paytm Share Price Today Live Updates : On the last trading day, Paytm's stock opened at 1005 and closed at 1000.5, reflecting a slight decline. The day's trading saw a high of 1024.95 and a low of 986. With a market capitalization of approximately 64,646.53 crore, the stock's performance is noteworthy, considering its 52-week high of 1063 and low of 310. The trading volume on the BSE was 289,226 shares. Paytm Share Price Live Updates: Consensus analysts rating is Hold Paytm Share Price Live Updates: The analyst recommendation trend is shown below with the current rating as Hold. These target price estimates are for the next 1 year. Paytm Share Price Live Updates: Paytm volume yesterday was 6 mn as compared to the 20 day avg of 8266 k Paytm Share Price Live Updates: The trading volume yesterday was 16.85% lower than the 20 day average. Yesterday’s NSE volume was 6 mn & BSE volume was 289 k. Paytm Share Price Live Updates: Paytm closed at ₹1000.5 on last trading day & the technical trend suggests Bullish near term outlook Paytm Share Price Live Updates: The stock traded in the range of 1024.95 & 986 yesterday to end at 1014.3. The stock is currently experiencing a strong bullish trend
Russia missile suspected in Azerbaijani plane crash, Moscow warns against 'hypotheses'
Team India batter Yashasvi Jaiswal enjoyed some fun banter with Australian pacer Mitchell Starc during India's second innings on Day 5 of the 4th Test at the MCG on Sunday. New Delhi: Yashasvi Jaiswal engaged in fun banter with Australian pacer Mitchell Starc during India’s 340-run chase in their second innings on Day 5 of the ongoing fourth Test between the two sides at the Melbourne Cricket Ground (MCG) in Melbourne on Monday. Jaiswal and Starc had a fun exchange between them after some bail-swapping antics. The incident happened during the 33rd over of India’s innings when Jaiswal was out in the middle with Rishabh Pant with Starc bowling for the hosts. The left-arm pacer went on to switch the bails on the non-striker’s end after a delivery to Pant. However, Jaiswal was quick to put the bails back in their original position as Starc walked back for his run-up. Some banter followed after the next delivery as Starc was caught on the stump mic asking Jaiswal if he believed in superstitions. Jaiswal responded by stating that he believed in himself before telling Starc how he is enjoying his life, facing someone like him in an important Test match for India. “Is that superstition? Why did you change the bails back,” Starc was heard telling Jaiswal on the stump-mic while walking back for his run-up. “I believe in myself, that’s why I am here. I am just enjoying this moment in my life,” Jaiswal responded. The banter between the duo created a buzz among the fans and a clip of the incident went viral on social media. Watch banter between Yashasvi Jaiswal and Mitchell Starc in 4th Test: This is not the first time Jaiswal and Starc have been involved in banter in the ongoing Border-Gavaskar Trophy 2024-25. The young Indian opener had teased the veteran Aussie quick about the lack of pace in his bowling during his stupendous knock of 161 runs in India’s second innings of the 1st Test match against Australia in Perth. Pant, Jaiswal steady the ship for India after poor start Jaiswal and Pant combined to steady the ship for India after their horror start in the 340-run chase in their second innings on Day 5. India lost skipper Rohit Sharma cheaply on 9 before Pat Cummins got rid of KL Rahul on a duck and Virat Kohli was dismissed by Starc on 5, leaving the visitors reeling at 33/3 in the 27th over. However, Pant and Jaiswal joined hands after lunch to help India stage a fightback in the run-chase. Jaiswal went on to complete his half-century as the duo added a 50-plus stand for the 4th wicket to keep India in the game. A lot will be riding on Pant and Jaiswal’s shoulders if India are to fancy their chances of pulling off an unlikely victory in the Test match and take 2-1 lead in the series. Click for more latest Cricket news . Also get top headlines and latest news from India and around the world at News9. Abhishek reports on all things sports for News9. He has been covering cricket extensively for more than five years now and is a keen follower of the game. From preserving newspaper cuts of his favourite sporting heroes to playing the game himself and then covering it from close quarters, cricket has stayed with him since childhood. He started his career with NewsX and has worked for some of the leading news organisations in the country, including Times Now and WION. He will probably be busy watching cricket/football when not crafting stories on sports and its heroes.
Florida State continues torrid star with rout of UMassWASHINGTON — Special counsel Jack Smith moved to abandon two criminal cases against Donald Trump on Monday, acknowledging that Trump’s return to the White House will preclude attempts to federally prosecute him for retaining classified documents or trying to overturn his 2020 election defeat. The decision was inevitable, since longstanding Justice Department policy says sitting presidents cannot face criminal prosecution. Yet it was still a momentous finale to an unprecedented chapter in political and law enforcement history, as federal officials attempted to hold accountable a former president while he was simultaneously running for another term. Trump emerges indisputably victorious, having successfully delayed the investigations through legal maneuvers and then winning re-election despite indictments that described his actions as a threat to the country's constitutional foundations. “I persevered, against all odds, and WON," Trump exulted in a post on Truth Social, his social media website. He also said that “these cases, like all of the other cases I have been forced to go through, are empty and lawless, and should never have been brought.” The judge in the election case granted prosecutors' dismissal request. A decision in the documents case was still pending on Monday afternoon. The outcome makes it clear that, when it comes to a president and criminal accusations, nothing supersedes the voters' own verdict. In court filings, Smith's team emphasized that the move to end their prosecutions was not a reflection of the merit of the cases but a recognition of the legal shield that surrounds any commander in chief. “That prohibition is categorical and does not turn on the gravity of the crimes charged, the strength of the Government’s proof, or the merits of the prosecution, which the Government stands fully behind,” prosecutors said in one of their filings. They wrote that Trump’s return to the White House “sets at odds two fundamental and compelling national interests: on the one hand, the Constitution’s requirement that the President must not be unduly encumbered in fulfilling his weighty responsibilities . . . and on the other hand, the Nation’s commitment to the rule of law.” In this situation, “the Constitution requires that this case be dismissed before the defendant is inaugurated,” they concluded. Smith’s team said it was leaving intact charges against two co-defendants in the classified documents case — Trump valet Walt Nauta and Mar-a-Lago property manager Carlos De Oliveira — because “no principle of temporary immunity applies to them.” Steven Cheung, Trump's incoming White House communications director, said Americans “want an immediate end to the political weaponization of our justice system and we look forward to uniting our country.” Trump has long described the investigations as politically motivated, and he has vowed to fire Smith as soon as he takes office in January. Now he will start his second term free from criminal scrutiny by the government that he will lead. The election case brought last year was once seen as one of the most serious legal threats facing Trump as he tried to reclaim the White House. He was indicted for plotting to overturn his defeat to Joe Biden in 2020, an effort that climaxed with his supporters' violent attack on the U.S. Capitol on Jan. 6, 2021. But the case quickly stalled amid legal fighting over Trump’s sweeping claims of immunity from prosecution for acts he took while in the White House. The U.S. Supreme Court in July ruled for the first time that former presidents have broad immunity from prosecution, and sent the case back to U.S. District Judge Tanya Chutkan to determine which allegations in the indictment, if any, could proceed to trial. The case was just beginning to pick up steam again in the trial court in the weeks leading up to this year’s election. Smith’s team in October filed a lengthy brief laying out new evidence they planned to use against him at trial, accusing him of “resorting to crimes” in an increasingly desperate effort to overturn the will of voters after he lost to Biden. In dismissing the case, Chutkan acknowledged prosecutors' request to do so “without prejudice,” raising the possibility that they could try to bring charges against Trump when his term is over. She wrote that is “consistent with the Government’s understanding that the immunity afforded to a sitting President is temporary, expiring when they leave office.” But such a move may be barred by the statute of limitations, and Trump may also try to pardon himself while in office. immunity afforded to a sitting President is temporary, expiring when they leave office. The separate case involving classified documents had been widely seen as legally clear cut, especially because the conduct in question occurred after Trump left the White House and lost the powers of the presidency. The indictment included dozens of felony counts accusing him of illegally hoarding classified records from his presidency at his Mar-a-Lago estate in Palm Beach, Florida, and obstructing federal efforts to get them back. He has pleaded not guilty and denied wrongdoing. The case quickly became snarled by delays, with U.S. District Judge Aileen Cannon slow to issue rulings — which favored Trump’s strategy of pushing off deadlines in all his criminal cases — while also entertaining defense motions and arguments that experts said other judges would have dispensed with without hearings. In May, she indefinitely canceled the trial date amid a series of unresolved legal issues before dismissing the case outright two months later. Smith’s team appealed the decision, but now has given up that effort. Trump faced two other state prosecutions while running for president. One them, a New York case involving hush money payments, resulted in a conviction on felony charges of falsifying business records. It was the first time a former president had been found guilty of a crime. The sentencing in that case is on hold as Trump's lawyers try to have the conviction dismissed before he takes office, arguing that letting the verdict stand will interfere with his presidential transition and duties. Manhattan District Attorney Alvin Bragg's office is fighting the dismissal but has indicated that it would be open to delaying sentencing until Trump leaves office. Bragg, a Democrat, has said the solution needs to balance the obligations of the presidency with “the sanctity of the jury verdict." Trump was also indicted in Georgia along with 18 others accused of participating in a sprawling scheme to illegally overturn the 2020 presidential election there. Any trial appears unlikely there while Trump holds office. The prosecution already was on hold after an appeals court agreed to review whether to remove Fulton County District Attorney Fani Willis over her romantic relationship with the special prosecutor she had hired to lead the case. Four defendants have pleaded guilty after reaching deals with prosecutors. Trump and the others have pleaded not guilty. Associated Press writers Colleen Long, Michael Sisak and Lindsay Whitehurst contributed to this story.None
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” ...Dollar Falls as Treasury Pick Tempers Trump Bets: Markets WrapUConn loses to Memphis in OT as rally falls short